|Previous Section||Index||Home Page|
14 Jan 2003 : Column 524Wcontinued
|Regional office area|
|Northern and Yorkshire||Trent||West Midlands||North West||Eastern||London||South East||South West||England|
|Generically prescribed items||44||31||31||50||28||36||45||28||292|
|Generically prescribed items||47||33||34||53||30||38||48||31||314|
|Generically prescribed items||50||36||37||56||33||41||52||34||339|
|Generically prescribed items||56||42||41||61||39||45||59||38||381|
|Generically prescribed items||62||47||45||68||43||49||65||42||422|
(2) The total number of prescription items includes dressings and appliances.
1. The data are from the Prescription Cost Analysis (PCA) system from the Prescription Pricing Authority (PPA) and cover prescription items dispensed by community pharmacists, appliance contractors, dispensing doctors and items personally administered.
2. Figures in the table have been rounded to the nearest million. Therefore the sum of the Regional Offices may not equal the England total.
14 Jan 2003 : Column 525W
Mr. Hutton: Applicants for work in the national health service are required to pass a number of pre-employment checks prior to receiving an unconditional offer of employment. These include verification of qualifications, identity, professional registration, criminal records and occupational health. Guidance on pre-employment checks was issued to NHS employers under the cover of a Direction for the Secretary of State, in June 2002.
Following the recommendations made by an expert working group the Government is currently consulting the professions and patient organisations regarding the introduction of additional health clearance for serious communicable diseases.
The information on the breakdown by region is shown in table 15 of the Statistical Bulletin, XStatistics from the Regional Drug Misuse Databases for the six months ending March 2001". The full Statistical Bulletin is available in the Library and on the Department's website at http://www.doh.gov.uk/public/sb0207.htm
Agency episodes reported by regional office area and health authority of treatment by type of agency during the period 1 October 200031 March 2001, provides information on the number of NHS funded general practices that have provided prescribing services to drug users by region.
|Northern and Yorkshire||322|
|South West||Not Available|
14 Jan 2003 : Column 526W
Ms Blears: The Departmentand this Government as a wholeplaces the highest priority on preventing illness, promoting the health of all and improving the health of the poorest fastest. This means tackling inequalities, and reducing mortality from cancer and coronary heart diseasethe two biggest killers in England. As well as reducing the burden caused by infectious diseases.
Mr. Peter Duncan: To ask the Secretary of State for Health what recent assessment he has received from the Health and Safety Executive regarding the effects of landfill sites on public health. 
The HSE contributes to a grant to the small area health statistics unit (SAHSU) at Imperial College, jointly with the Department of Health, the Department for Environment, Food and Rural Affairs, the Environment Agency, the Scottish Executive, the National Assembly of Wales and the Northern Ireland Department of Health, Social Services and Public Safety. SAHSU was commissioned to carry out a national study of birth outcomes and cancer around landfill sites.
The results for birth outcomes were published in the British Medical Journal in 2001 (Elliott et al BMJ 2001: 323: 3638: available at http://www.bmj.com). The results for the cancer outcomes were published in the British Journal of Cancer in 2002 (Jarup et al 2002: 86: 17326). A fuller report of the study may be found at the Department of Health website at: http://www.doh.gov.uk/pdfs/report augl3.pdf. The study found a small increase in congenital anomalies in populations living close to landfill sites. There was no suggestion of excess risks of cancer associated with landfill sites. The Department sought advice on the study from the independent expert Committee on the Toxicity of Chemicals in Food, Consumer Products and the Environment (COT). COT noted that the findings for birth outcomes were not consistent, and that the study provided no evidence that the rates of anomalies increased after sites had opened. The opinion of the COT may be found at: http://www.doh.gov.uk/cotnonfood/landfil.htm.
14 Jan 2003 : Column 527W
(b) received from the Scottish Executive regarding the purchase of Life Resources Incorporated; and what consultations have taken place between his Department and the Scottish Executive regarding access to resources stored in Life Resources Incorporated; 
(3) what role the Scottish Executive played in the purchase of Life Resources Incorporated; and whether the Scottish Executive will have representation at board level; 
(4) what representations were received from the Scottish Executive regarding bonus payments to be paid out in future years to Life Resources Incorporated; 
(5) whether contracts on behalf of the NHS in Scotland have been made with Life Resources Incorporated, for the purchase of plasma products that are free of vCJD, for use within the NHS in Scotland. 
Ms Blears [holding answer 13 January 2003]: The Scottish National Blood Transfusion Service (SNBTS) has its own independent sources of non-UK plasma. The Scottish Executive were therefore not involved in the Government's decision to purchase Life Resources Incorporated to secure supplies of non-UK plasma for the national health service in England.Accordingly, no consultations or financial transactions took place with the Scottish Executive concerning the purchase of Life Resources and the Scottish Executive will have no involvement in the future management of the company.
SNBTS is not currently supplied with plasma by Life Resources Incorporated. Should SNBTS decide in future to tender for plasma supplies, Life Resources could be one of a number of commercial plasma suppliers that might compete for this contract.
|Next Section||Index||Home Page|